Pages that link to "Q50968485"
Jump to navigation
Jump to search
The following pages link to Maura Marcucci (Q50968485):
Displaying 50 items.
- Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B (Q24195006) (← links)
- A generalised model for individualising a treatment recommendation based on group-level evidence from randomised clinical trials (Q30543580) (← links)
- Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study (Q30837974) (← links)
- Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data (Q30889099) (← links)
- Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study (Q30906342) (← links)
- Evaluation of safety and effectiveness of factor VIII treatment in haemophilia A patients with low titre inhibitors or a personal history of inhibitor. Patient Data Meta-analysis of rAFH-PFM Post-Authorization Safety Studies (Q30959893) (← links)
- Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol (Q31088061) (← links)
- Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review (Q34145656) (← links)
- Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey (Q34420450) (← links)
- Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis (Q34603112) (← links)
- Inhibitor development in previously treated hemophilia A patients: a systematic review, meta-analysis, and meta-regression (Q34784564) (← links)
- A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. (Q34819923) (← links)
- Patient data meta-analysis of Post-Authorization Safety Surveillance (PASS) studies of haemophilia A patients treated with rAHF-PFM. (Q35209354) (← links)
- Predictors of clinical events occurring during hospital stay among elderly patients admitted to medical wards in Italy (Q36011737) (← links)
- Management of patients with unprovoked venous thromboembolism: an evidence-based and practical approach (Q36718482) (← links)
- Efficacy of ultra-micronized palmitoylethanolamide (um-PEA) in geriatric patients with chronic pain: study protocol for a series of N-of-1 randomized trials. (Q37138714) (← links)
- Bayesian approach to the assessment of the population-specific risk of inhibitors in hemophilia A patients: a case study (Q37381565) (← links)
- Clinical trials and haemophilia: does the Bayesian approach make the ideal and desirable good friends? (Q37497562) (← links)
- Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review (Q37719683) (← links)
- Perioperative management of antiplatelet therapy in patients with a coronary stent who need noncardiac surgery: a systematic review of clinical practice guidelines (Q38127571) (← links)
- Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study (Q38374411) (← links)
- Mild cognitive decline. A position statement of the Cognitive Decline Group of the European Innovation Partnership for Active and Healthy Ageing (EIPAHA). (Q38621153) (← links)
- Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA. (Q38779963) (← links)
- Emergency physician accuracy in interpreting electrocardiograms with potential ST-segment elevation myocardial infarction: Is it enough? (Q39271833) (← links)
- Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People (Q40181568) (← links)
- Changes in clinical outcomes for community-dwelling older people exposed to incident chronic polypharmacy: a comparison between 2001 and 2009. (Q40188560) (← links)
- A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation (Q40287579) (← links)
- Gender difference in drug use in hospitalized elderly patients. (Q40697364) (← links)
- Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia (Q41033872) (← links)
- Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards (Q42791455) (← links)
- Prophylaxis of venous thromboembolism in elderly patients with multimorbidity (Q43513337) (← links)
- Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences (Q43691261) (← links)
- The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy (Q44347241) (← links)
- Prognostic value of estimated glomerular filtration rate in hospitalized elderly patients (Q44452297) (← links)
- Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010. (Q44500986) (← links)
- Drug-drug interactions in a cohort of hospitalized elderly patients. (Q44670806) (← links)
- Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study (Q44881260) (← links)
- Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly (Q45739067) (← links)
- Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study (Q45764426) (← links)
- Oral anticoagulant use in octogenarian European patients with atrial fibrillation: A subanalysis of PREFER in AF. (Q45863853) (← links)
- Concentrate-related inhibitor risk: is a difference always real? (Q45872627) (← links)
- Prevalence and characteristics of antidepressant drug prescriptions in older Italian patients. (Q46015317) (← links)
- Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). (Q47923995) (← links)
- Prevalence of potentially inappropriate medications and risk of adverse clinical outcome in a cohort of hospitalized elderly patients: results from the REPOSI Study. (Q48105632) (← links)
- Padua prediction score or clinical judgment for decision making on antithrombotic prophylaxis: a quasi-randomized controlled trial. (Q48154374) (← links)
- Type and intensity of FVIII exposure on inhibitor development in PUPs with haemophilia A. A patient-level meta-analysis (Q50968397) (← links)
- Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis (Q57616514) (← links)
- Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly (Q58297769) (← links)
- Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation (Q58376526) (← links)
- Risk factors for hospital readmission of elderly patients (Q58376533) (← links)